男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Current measures effective for variants

By WANG XIAOYU | CHINA DAILY | Updated: 2022-07-22 09:08
Share
Share - WeChat
An asymptomatic carrier of COVID-19 (center) waves goodbye to medical workers at a makeshift hospital after finishing his medical observation in Zhangye, Gansu province, on Wednesday. He will undergo a seven-day health monitoring at home. [Photo by WANG JIANG/FOR CHINA DAILY]

Early detection underlined in latest guideline to tackle Omicron strain

China's COVID-19 disease control measures can effectively tackle the BA.4 and BA.5 subvariants of Omicron, and existing vaccines can offer protection against the two highly contagious strains, a public health expert said on Thursday.

Dong Xiaoping, chief virologist at the Chinese Center for Disease Control and Prevention, said during a news conference that the BA.4 and BA.5 strains are more transmissible than other subvariants of Omicron, but their pathogenicity-meaning the virus' ability to attack human bodies-currently shows no major difference from other strains.

With BA.4 and BA.5 variants having become dominant in some regions and triggered fresh infection spikes in parts of Europe and America, he said the incidence and mortality rates of the disease will likely rise, citing results of epidemiological models.

"However, there is no evidence to show that non-pharmaceutical interventions (such as mask wearing and keeping social distance) will no longer work," he said. "In other words, China's current virus containment measures remain effective."

To better cope with the highly transmissible and stealthy Omicron strain, Dong said the latest disease control guideline, issued by the National Health Commission in late June, has underscored early detection of the virus.

"The new guideline has clarified monitoring rules for high-risk workers, added drugs into its monitoring system and used antigen tests as an additional tool," he said. "Deployment of such new strategies and technologies will greatly boost our capability to identify Omicron cases."

Research into upgraded COVID-19 vaccines tailored to emerging strains is underway, according to Dong, but more time is needed to roll out third-stage human trials and decide on whether to replace current vaccines based on the original strain.

Dong noted that some in-vitro experiments demonstrate that the effects of neutralizing antibodies generated following immunization on the two new strains decreased, but whether the protection of existing vaccines will diminish in real-world cases is unclear.

"Domestic and foreign experts believe that current vaccines remain effective, and getting vaccinated and, in particular, boosted, is still the best approach to fend off the virus for the elderly and those with underlying diseases," he said.

As of Wednesday, China had fully vaccinated nearly 89.7 percent of its population and 84.5 percent of people aged 60 and above, according to the National Health Commission.

Dong added that the novel coronavirus will continue to mutate for a long time and Omicron won't be the last mutation. "We will focus on monitoring new strains as well as their transmissibility, pathogenicity and ability to evade immunity," he said.

On the mainland, 21 provincial-level regions had reported new locally transmitted infections in the past week, some being caused by BA.4 or BA.5.

He Qinghua, an official with the commission's bureau of disease prevention and control, said that new outbreaks in Gansu and Henan provinces, as well as the Guangxi Zhuang autonomous region are developing.

"Most domestic infection clusters can be contained in a short period and the epidemic's impact is limited," he said. "The capability and efficiency of local disease control work has improved."

On Wednesday, the mainland reported 148 locally transmitted, confirmed infections and 678 asymptomatic cases, compared with 108 and 827 respectively for the previous day.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 尚志市| 重庆市| 大安市| 壤塘县| 云安县| 车致| 福泉市| 都安| 大悟县| 灵丘县| 海伦市| 崇明县| 开鲁县| 宣化县| 通江县| 揭东县| 舒城县| 镇康县| 巴林左旗| 涪陵区| 陆良县| 花莲市| 河南省| 秦皇岛市| 葫芦岛市| 和龙市| 辽源市| 留坝县| 赣榆县| 永丰县| 关岭| 偃师市| 雅江县| 景谷| 沙坪坝区| 台南市| 崇左市| 平罗县| 东阿县| 修水县| 诸暨市| 双城市| 元江| 商丘市| 昌黎县| 上栗县| 塘沽区| 奉化市| 平山县| 南平市| 厦门市| 桃园市| 祁连县| 基隆市| 容城县| 南乐县| 梁山县| 崇义县| 宁蒗| 忻城县| 化德县| 安康市| 大安市| 小金县| 岳西县| 乐业县| 沙雅县| 沙河市| 高平市| 青河县| 丰都县| 沙洋县| 新绛县| 寿阳县| 武冈市| 舒城县| 南平市| 太保市| 渑池县| 孟州市| 高碑店市| 牟定县|